Unknown

Dataset Information

0

HnRNP-A1 binds to the IRES of MELOE-1 antigen to promote MELOE-1 translation in stressed melanoma cells.


ABSTRACT: The major challenge in antigen-specific immunotherapy of cancer is to select the most relevant tumor antigens to target. To this aim, understanding their mode of expression by tumor cells is critical. We previously identified a melanoma-specific antigen, melanoma-overexpressed antigen 1 (MELOE-1)-coded for by a long noncoding RNA-whose internal ribosomal entry sequence (IRES)-dependent translation is restricted to tumor cells. This restricted expression is associated with the presence of a broad-specific T-cell repertoire that is involved in tumor immunosurveillance in melanoma patients. In the present work, we explored the translation control of MELOE-1 and provide evidence that heterogeneous nuclear ribonucleoprotein A1 (hnRNP-A1) binds to the MELOE-1 IRES and acts as an IRES trans-activating factor (ITAF) to promote the translation of MELOE-1 in melanoma cells. In addition, we showed that endoplasmic reticulum (ER) stress induced by thapsigargin, which promotes hnRNP-A1 cytoplasmic translocation, enhances MELOE-1 translation and recognition of melanoma cells by a MELOE-1-specific T-cell clone. These findings suggest that pharmacological stimulation of stress pathways may enhance the efficacy of immunotherapies targeting stress-induced tumor antigens such as MELOE-1.

SUBMITTER: Charpentier M 

PROVIDER: S-EPMC8807352 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote MELOE-1 translation in stressed melanoma cells.

Charpentier Maud M   Dupré Emilie E   Fortun Agnès A   Briand Floriane F   Maillasson Mike M   Com Emmanuelle E   Pineau Charles C   Labarrière Nathalie N   Rabu Catherine C   Lang François F  

Molecular oncology 20210912 3


The major challenge in antigen-specific immunotherapy of cancer is to select the most relevant tumor antigens to target. To this aim, understanding their mode of expression by tumor cells is critical. We previously identified a melanoma-specific antigen, melanoma-overexpressed antigen 1 (MELOE-1)-coded for by a long noncoding RNA-whose internal ribosomal entry sequence (IRES)-dependent translation is restricted to tumor cells. This restricted expression is associated with the presence of a broad  ...[more]

Similar Datasets

| S-EPMC5416833 | biostudies-literature
| S-EPMC5312342 | biostudies-literature
| S-EPMC7544202 | biostudies-literature
| S-EPMC5610934 | biostudies-literature
| S-EPMC3783476 | biostudies-literature
| S-EPMC8197126 | biostudies-literature
| S-EPMC1525244 | biostudies-literature
| S-EPMC7000962 | biostudies-literature
| S-EPMC3384309 | biostudies-literature
| S-EPMC8700186 | biostudies-literature